Tehran University of Medical Sciences

Science Communicator Platform

Share By
Mortality and Morbidity Benefit After Influenza Vaccination in High Cardiovascular Risk Population: A Systematic Review and Meta-Analysis Publisher Pubmed



Hosseini K ; Dastjerdi P ; Sahzabi RY ; Alipoor A ; Masanabadi M ; Rezvanian P ; Daryabari Y ; Mehdizadeh M ; Soleimani S ; Modin D ; Skaarup KG ; Bieringsorensen T
Authors

Source: American Journal of Cardiology Published:2026


Abstract

Influenza infection increases cardiovascular risk in patients with ischemic heart disease (IHD) or heart failure (HF). This updated meta-analysis evaluated the cardiovascular benefits of influenza vaccination in these populations. Two complementary approaches were used: an individual patient data (IPD) meta-analysis for the primary outcome (reconstructed from published Kaplan–Meier curves) and conventional study-level random-effects meta-analyses for all outcomes. Cox models were used to estimate pooled hazard ratios (HRs). Heterogeneity was explored using subgroup, sensitivity, and meta-regression analyses, and study quality was assessed with RoB 2 and ROBINS-I. Twenty-three studies (7 RCTs, 16 observational; n = 1,137,377) met inclusion criteria. Influenza vaccination significantly reduced all-cause mortality (HR = 0.72; 95% CI: 0.63 to 0.82) and cardiovascular mortality (HR = 0.77; 95% CI: 0.67 to 0.89). Vaccinated patients also had a lower risk of MI (HR = 0.81; 95% CI: 0.78 to 0.83), whereas effects on stroke (HR = 0.88; 95% CI: 0.68 to 1.14) and MACE (HR = 0.81; 95% CI: 0.57 to 1.15) were not significant. Reconstructed individual data (n = 22,443) demonstrated a 38% mortality reduction (HR = 0.62; 95% CI: 0.57 to 0.67), with the greatest benefit in the first four months postvaccination. Effects were consistent across age, disease type, study design, and follow-up duration. In conclusion, Influenza vaccination markedly lowers mortality and provides cardiovascular protection in patients with IHD or HF, supporting annual vaccination as an effective secondary prevention strategy. © 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Other Related Docs
8. Influenza Vaccination Attitudes of Health Care Workers in Iran, International Journal of Pharmacy and Technology (2016)
11. Predictors of Mortality in Patients With Covid-19–A Systematic Review, European Journal of Integrative Medicine (2020)
13. Feasibility and Effectiveness of Vaccines for Covid-19: An Umbrella Review, Archives of Academic Emergency Medicine (2025)
15. Obesity As an Independent Risk Factor for Covid-19 Severity and Mortality, Cochrane Database of Systematic Reviews (2023)